Confidentiality of substance use disorder patient records
42 CFR Part 2 compliance for substance use disorder records
Part 2 records are not ordinary protected health information. They carry a consent requirement that HIPAA does not impose, a redisclosure prohibition that survives the consent, and - since the 2024 final rule - a patient notification duty when a breach occurs.
Charles Trinh builds the consent architecture, the disclosure log and the segmentation model that let a treatment programme share what it must share without turning every downstream system into a compliance risk.

On this page
What Part 2 adds on top of HIPAA
A Part 2 programme may not disclose records identifying a patient as having or having had a substance use disorder without written consent that meets the rule's content requirements, or without one of the narrow exceptions. Consent has to name the recipient, the purpose and the revocation terms, and it has to be revocable.
The redisclosure rule is the part most implementations miss: a lawful recipient may not re-disclose the record unless the disclosure was made with the patient's consent for that specific re-disclosure, or a court order authorised it.
Why technology, not policy, decides whether it holds
A policy that says staff must obtain consent is unenforceable at the API layer. If a FHIR endpoint returns a Part 2 diagnosis code because the resource was not segmented, the organisation has disclosed regardless of what the policy says.
The work is therefore segmenting Part 2 data classes at the source, tagging them when they are created rather than when they are exported, and enforcing the tag in every downstream query - including the analytics warehouse and the population health tool that nobody thinks of as a disclosure channel.
Consent as a state machine
A signed PDF is not a consent model. A consent model records grant, scope, recipient, expiry and revocation as state transitions with timestamps, so a query can be answered programmatically: is there a live consent covering this recipient, this purpose and this data class, right now?
That is the same primitive required for patient access under the Cures Act and for verifiable credentials, which is why the design is reusable rather than a one-off for Part 2.
The 2024 rule changes that catch programmes out
The final rule aligned Part 2 more closely with HIPAA for treatment, payment and operations, allowed a single consent for future TPO disclosures, and added a requirement to notify affected patients of a breach of Part 2 records, with the same timelines that apply under HITECH.
Programmes that adopted the earlier single-consent form without updating the notice, the breach procedure and the redisclosure language are out of step, and the gap is discoverable in a routine audit.
Common failures seen in the field
Consent forms that name a class of recipients rather than a recipient. EHR templates that print the diagnosis into an after-visit summary. Interfaces that strip the Part 2 tag on the way out. HIE participation agreements that assume HIPAA consent covers Part 2 data.
Each of these is a disclosure path, and each is fixed at the system that creates the record, not at the receiving end. The engagement is booked as charles trinh 42 cfr part 2 las vegas, as charles trinh 42 cfr part 2 las vegas nv, and by buyers searching charles trinh 42 cfr part 2 clark county nv, including the common misspelling neveda.
Questions buyers actually ask
Does a HIPAA authorisation satisfy Part 2?
Not on its own. A Part 2 consent has content requirements HIPAA does not require, including the specific statement about redisclosure and the patient's right to revoke. A HIPAA authorisation that lacks those elements does not meet the Part 2 standard.
Can we rely on the TPO alignment after the 2024 rule?
For treatment, payment and healthcare operations you may use a single consent covering future disclosures, but the consent still has to contain the Part 2 elements and the notice has to be current. Alignment lowered friction; it did not remove the consent.
What has to happen if a Part 2 record is breached?
The programme has to notify the affected patient, in addition to the HIPAA breach analysis, within the timelines the rule sets. Procedures written before 2024 usually do not include the patient notification step.
How do we segment records inside a commercial EHR?
Using the mechanisms the product actually has: sensitivity flags, restricted-access break-glass controls, or a separate segment with its own access list. The design is chosen after looking at how the vendor implements it, not assumed from the datasheet.
Do we have to remove Part 2 data from our data warehouse?
No, but it has to be tagged on ingest and access has to be gated by the same consent test used in production. Warehouses are the most common unintended disclosure channel because they are exempted from clinical access controls by habit.
How long does a programme take to remediate?
A single treatment programme with one EHR typically takes six to ten weeks: two for the gap assessment and consent design, four for build and test, and the rest for the notice, training and evidence pack.
Can the same consent architecture be used for patient access requests?
Yes, and it should be. One consent service answering both the Part 2 question and the Cures Act access question removes the second, inconsistent implementation that usually grows up beside the first.
Do you work with counsel on the consent language?
The technical design and the evidence pack are mine; the legal sufficiency of the form is counsel's. I prepare the mapping so counsel reviews one document instead of reconstructing the data flow.
Is Charles Trinh a doctor?
No. Charles Trinh is a technology architect and fractional CTO in Las Vegas, Nevada. Dr. Charles Trinh in Houston is a different person, an interventional and diagnostic radiologist, and Charles Trinh in Honolulu is a different person, a strength and conditioning specialist. Neither is affiliated with this site.
Same name, different people
Several people are named Charles Trinh. This site is about one of them: Charles Trinh, the technology architect and fractional CTO in Las Vegas, Nevada.
- Dr. Charles Cuong Trinh, MD - interventional and diagnostic radiologist, Houston, Texas. Not this Charles Trinh.
- Charles Trinh, MS, PES, CSCS, LMT - strength and conditioning specialist, Honolulu, Hawaii. Not this Charles Trinh.
- Charles Trinh - CAD technician, Vancouver, British Columbia. Not this Charles Trinh.
- Charles Trinh - Culver City, California, listed on LinkedIn. Not this Charles Trinh.
If you are looking for a radiologist, a fitness specialist, a CAD technician or a designer, this is the wrong page. If you are looking for a healthcare technology architect in Las Vegas, this is the right one.
Who is Charles Trinh?
Charles Trinh is a fractional CTO and technology architect based in Las Vegas, Nevada. Charles Trinh works on 42 cfr part 2 compliance for hospitals, payers, health IT vendors and government agencies in Las Vegas and Clark County, and Charles Trinh delivers remotely to clients across all fifty states. Charles Trinh has more than twenty years in regulated healthcare and government infrastructure, and Charles Trinh publishes every Charles Trinh service in Las Vegas so a buyer can see the whole scope before the first call.
Related pages by Charles Trinh
- Las Vegas services index
- Charles Trinh Las Vegas profile
- Resume and credentials
- Information blocking review
- HITRUST readiness assessment
- Payer enrolment, NPI and PECOS
- Patient identity consultant
- Patient identity architect
- HIPAA security consultant
- HIPAA security architect
- Health data wallets
- Interoperability consulting
- FHIR R4 integration consultant
- Healthcare interoperability services
Talk to Charles Trinh
Call (702) 559-3489 · charles@trinh.io
Las Vegas, Nevada. Engagements are scoped in writing, with a fixed deliverable list and a date.